Published online Apr 16, 2024. doi: 10.12998/wjcc.v12.i11.1857
Peer-review started: November 28, 2023
First decision: January 17, 2024
Revised: January 25, 2024
Accepted: March 21, 2024
Article in press: March 21, 2024
Published online: April 16, 2024
Processing time: 134 Days and 17.5 Hours
In this editorial, we comment on an article by Ruan et al published in a recent issue of the World Journal of Clinical Case. Pulmonary meningothelial proliferative lesions, including primary pulmonary meningiomas, minute pulmonary meningothelial-like nodules, and metastatic pulmonary meningiomas are rare pulmonary lesions. These lesions are difficult to differentiate from lung cancers based on clinical and imaging manifestations. Herein, we briefly introduce the clinical, imaging, and pathological characteristics of these lesions and discuss their pathogenesis to strengthen the current understanding of pulmonary meningothe
Core Tip: Primary pulmonary meningiomas (PPM) and minute pulmonary meningothelial-like nodules (MPMN) are rare pulmonary lesions, which are difficult to differentiate from lung cancers due to similarities in clinical and imaging manifestations. To avoid misdiagnosis and overtreatment, PPM and MPMN should be considered in the differential diagnoses of pulmonary nodules of difficult clinical and/or imaging procedure diagnosis, particularly of asymptomatic patients. Differentiating PPM and MPMN from other pulmonary nodule diseases and assessing the malignancy of PPMs are difficult using only imaging-procedures, and histopathological examination thus remains the gold standard diagnostic procedure. Enhancing our understanding of MPMNs and PPMs and elucidating their pathogenesis will aid in the accurate differentiation of these lesions, to improve the clinical management of patients.